Efficient Performance Of The Sartoflow® Expert SU In ADC Processes

In the biopharmaceutical industry, antibody-drug conjugates (ADCs) represent a significant area of growth. Today, downstream processing steps are typically carried out as individual unit operations. However, manufacturers require more integrated solutions to increase the robustness of their ADC processes.

Explore the capabilities of a fully automated, single-use (SU) tangential flow filtration (TFF) system that can be configured to perform the incubation, purification, and concentration steps of ADC synthesis.